Abstract
Six monoclonal antibodies raised against Escherichia coli 0111 and against its rough mutant (chemotype Rc) were studied. One IgG2A against E. coli J5, one IgM anti-J5 and one IgG2a anti-0111 monoclonal antibody did not bind to lipopolysaccharides of the homologous strain, but cross-reacted with heterologous gram-negative rods in an enzyme-linked immunosorbent assay. These three monoclonal antibodies activated complement when incubated with homologous or heterologous strains, but were opsonic neither in the presence nor in the absence of complement. The other three monoclonal antibodies were directed against lipopolysaccharide of the homologous strain, but showed no cross-reactivity. However, these antibodies cross-reacted when bacteria were exposed to low concentrations of antibiotics (monobactams). The IgG3 and one IgM anti-J5 monoclonal antibodies activated complement and were opsonic only in the presence of complement. The IgM anti-0111 monoclonal antibody activated complement and was opsonic both in the presence and absence of complement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Luderitz O, Staub AM, Westphal O (1966) Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. Bacteriological Reviews 30: 192–255.
Braude AI, Douglas H (1972) Passive immunization against the local Schwartzman reaction. J Immunol 108: 505–512.
Davis CE, Ziegler EJ, Arnold KF (1978) Neutralization of meningococ- cal endotoxin by antibody to core glycolipid. J Exp Med 147: 1007–1017.
Johns M, Skehill A, McCabe WR (1983) Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to 0 and rough antigens against endotoxin. J Infect Dis 147: 57–67.
Marks MI, Ziegler EJ, Douglas H, Corbeil LB, Braude AI (1982) Induc- tion of immunity against lethal Haemouhilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J Clin Invest 69: 742–749.
McCabe WR (1972) Immunization with R mutants of Salmonella minnesota. I. Protection against challenge with heterologous gram-negative bacilli. J Immunol 108: 601–610.
Young LS, Stevens P, Ingram J (1975) Functional role of antibody against “core” glycolipid of Enterobacteriaceae. J Clin Invest 56: 850–861.
Ziegler EJ, Douglas H, Sherman JE, Davis CE, Braude AI (1973) Treat- ment of E. coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. J Immunol 111: 433–438.
Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas BS, Braude AI (1982) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. New Eng J Med 307: 1225–1230.
Wolff SM (1982) The treatment of gram-negative bacteremia and shock. Editorial. New Eng J Med 307: 1267–1268.
Kirkland TN, Ziegler EJ (1984) An immunoprotective monoclonal anti- body to lipopolysaccharide. J Immunol 132: 2590–2592.
Nelles MJ, Niswander CA (1984) Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Infect Immunity 46: 677–681.
Vreede RW, Leuvenink J, Bouter AS, Brouwer EC, Marcelis JH, Verhoef J (1986) Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli 0111 and its rough mutant J5. Eur J Clin Microbiol 5: 141–147.
Ivanoff B, André C, Fontanges R, Jourdan G (1982) Secondary immune response to oral and nasal rough mutant strains of Salmonella tvphimurium. Annales d’Immunologie (L’Institut Pasteur) 133 D: 61–70.
Shulman M (1978) A better cell line for making hybridomas secreting specific antibodies. Nature (London) 276: 269–270.
Kohler G, Milstein C (1975) Continuous culture of fused cells se- creting antibody of predefined specificity. Nature (London) 256: 495–497.
Fazekas de St. Groth S, Scheidegger D (1980) Production of monoclo- nal antibodies: strategy and tactics. J Immunol Methods 35:1–21.
Westphal 0, Jann K (1965) Bacterial lipopolysaccharides. Methods of Carbohydrate Research 5: 83–91.
Galanos C, Luderitz 0, Westphal 0 (1969) A new method for the extraction of R lipopolysaccharides. Eur J Biochem 9: 245–249.
Bos ES, van der Doelen AA, van Rooy N, Schuurs AHWM (1981) 3,3’, 5,5’-Tetramethylbenzidine as a ames test negative chromogen for horse-radish-peroxidase in enzyme-immunoassay. J Immunoassay 2: 187–204.
Klerx JPAM, Beukelman CJ, van Dijk H, Willers JMN (1983) Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Methods 63: 215–220.
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scandinavian J Clin Invest 97: S77–89.
Verbrugh HA, Peters R, Peterson PK, Verhoef J (1978) Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leukocytes. J Clin Path 31: 539–545.
Verhoef J, Peterson PK, Quie PG (1977) Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using 3H-thymidine labeled bacteria. J Immunol Methods 14: 303–311.
Rosenberg-Arska M, Salters MEC, van Strijp JAG, Geuze JJ, Verhoef J (1985) Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes. Infect Immun 50: 852–859.
Overbeek BP, Schellekens JFP, Lippe W, Dekker HAT, Verhoef J (1987) Carumonam enhances reactivity of E. coli with mono-and polyclonal antisera to rough mutant E. coli J5. J Clin Microbiol 25: 1009–1013.
Vreede RW, Marcelis JH, Verhoef J (1986) Antibodies raised against rough mutants of E. coli and Salmonella strains are opsonic only in the presence of complement. Infect Immun 52: 892–896.
Couderc J, Kazatchkine MD, Ventura M, Thien Duc H, Maillet F, Thobie N, Liacopoulos P (1985) Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1–2A monovalent anti-TNP antibody bound to TNP-conjugated cells. J Immunol 134: 486–491.
Betz J, Isliker H (1981) Antibody-independent interactions between Escherichia coli J5 and human complement components. J Immunol 127: 1748–1754.
Tenner AJ, Ziccardi RJ, Cooper NR (1984) Antibody-independent Cl ac- tivation by E. coli. J Immunol 133: 886–891.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Verhoef, J., Vreede, R.W., Bouter, A.S. (1988). The Opsonic Capacity of Monoclonal Antibodies Against Escherichia Coli 0111 and Its Rough Mutant E. Coli J5. In: Cabello, F.C., Pruzzo, C. (eds) Bacteria, Complement and the Phagocytic Cell. NATO ASI Series, vol 24. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85718-8_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-85718-8_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85720-1
Online ISBN: 978-3-642-85718-8
eBook Packages: Springer Book Archive